Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)
China flag China · Delayed Price · Currency is CNY
7.58
-0.14 (-1.81%)
Sep 6, 2024, 3:00 PM CST

Tonghua Dongbao Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
15,02221,48318,21022,16126,99925,730
Upgrade
Market Cap Growth
-20.31%17.97%-17.83%-17.92%4.93%-8.99%
Upgrade
Enterprise Value
14,87320,92116,96621,32126,74125,526
Upgrade
Last Close Price
7.5810.568.759.8611.8311.04
Upgrade
PE Ratio
32.3017.9011.0715.4025.7227.60
Upgrade
PS Ratio
5.976.996.556.789.349.26
Upgrade
PB Ratio
2.312.982.783.564.865.14
Upgrade
P/FCF Ratio
66.1241.8449.1938.2337.8829.95
Upgrade
P/OCF Ratio
24.7224.9421.1018.7722.6522.33
Upgrade
EV/Sales Ratio
6.076.806.116.529.259.19
Upgrade
EV/EBITDA Ratio
16.5414.3816.4215.3520.5823.31
Upgrade
EV/EBIT Ratio
20.8316.4719.2317.1223.3627.09
Upgrade
EV/FCF Ratio
65.4740.7545.8336.7837.5229.71
Upgrade
Debt / Equity Ratio
0.060.020.000.000.000.03
Upgrade
Debt / EBITDA Ratio
0.400.100.000.000.000.12
Upgrade
Debt / FCF Ratio
1.580.290.010.000.000.15
Upgrade
Asset Turnover
0.350.420.420.530.520.51
Upgrade
Inventory Turnover
0.690.911.051.091.000.95
Upgrade
Quick Ratio
2.773.928.165.816.404.16
Upgrade
Current Ratio
4.995.4112.698.059.236.32
Upgrade
Return on Equity (ROE)
6.94%16.97%24.77%22.22%17.61%16.62%
Upgrade
Return on Assets (ROA)
6.43%10.93%8.31%12.63%12.83%10.89%
Upgrade
Return on Capital (ROIC)
6.63%11.41%8.63%13.21%13.37%11.41%
Upgrade
Earnings Yield
3.09%5.44%8.69%5.90%3.44%3.15%
Upgrade
FCF Yield
1.51%2.39%2.03%2.62%2.64%3.34%
Upgrade
Dividend Yield
3.30%2.37%5.72%3.04%1.77%1.81%
Upgrade
Payout Ratio
110.45%42.49%69.27%32.49%43.40%50.15%
Upgrade
Buyback Yield / Dilution
3.98%1.15%2.04%-1.12%0.32%0.85%
Upgrade
Total Shareholder Return
7.28%3.52%7.76%1.93%2.09%2.66%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.